Daily Snapshot

Health headlines for Tuesday, March 24, 2026

Health headlines for 2026-03-24 focused on 3 major developments: 1) Federal vaccine adviser departs ACIP (STAT News) 2) Opinion: We’re launching a new CMS pilot program to help children with complex conditions (STAT News) 3) STAT+: FTC strikes proposed deal with CVS over charges its PBM manipulated insulin prices, impeded access (STAT News) Across these stories, coverage emphasized high-impact updates, policy shifts, and events with broad audience relevance. Together they provide a representative view of the day in health news before diving into each full report.

Why it matters: This snapshot shows where health attention concentrated on 2026-03-24, highlighting the themes, entities, and geographies that dominated publisher coverage. Because ranking blends freshness, engagement, and source diversity, it helps separate signal from noise. Use it as a quick daily briefing and then open the top stories for fuller context.

Key Points

3 highlights
  1. Federal vaccine adviser departs ACIP

    Sources: #1 STAT News
  2. Opinion: We’re launching a new CMS pilot program to help children with complex conditions

    Sources: #2 STAT News
  3. STAT+: FTC strikes proposed deal with CVS over charges its PBM manipulated insulin prices, impeded access

    Sources: #3 STAT News

Top 10 Stories

Ranked by daily score
  1. Federal vaccine adviser departs ACIP
    #1 Score 80
    Federal vaccine adviser departs ACIP

    Robert Malone, an outspoken doctor and ally of RFK Jr., is stepping away from a panel of federal vaccine advisers after a federal judge blocked the panel’s work.

    STAT News 2 hours ago
  2. Opinion: We’re launching a new CMS pilot program to help children with complex conditions
    #2 Score 61
    Opinion: We’re launching a new CMS pilot program to help children with complex conditions

    CMS wants “to turn this shoddy patchwork of care into a seamless tapestry,” write CMS Administrator Mehmet Oz and Center for Medicare and Medicaid Innovation Director Abe Sutton.

    STAT News 6 hours ago
  3. STAT+: FTC strikes proposed deal with CVS over charges its PBM manipulated insulin prices, impeded access
    #3 Score 54
    STAT+: FTC strikes proposed deal with CVS over charges its PBM manipulated insulin prices, impeded access

    The FTC said the settlement will save Americans up to $7 billion in out-of-pocket costs over 10 years.

    STAT News 6 hours ago
  4. MDMA Therapy in Australia Shows Results for PTSD Patients, but the Cost Is Limiting Access
    #4 Score 49
    MDMA Therapy in Australia Shows Results for PTSD Patients, but the Cost Is Limiting Access

    The country’s experiment with psychedelic medicine has led to positive outcomes, psychiatrists say, but also highlights the limitations of the nascent field.

    NYT Health 12 hours ago
  5. STAT+: Drug company penalties for paying kickbacks to doctors failed to dent bottom lines, analysis finds
    #5 Score 45
    STAT+: Drug company penalties for paying kickbacks to doctors failed to dent bottom lines, analysis finds

    Drugmakers that were penalized for kickbacks paid only 2.2% of their U.S. revenue generated by selling drugs that were the focus of the alleged violations during the past quarter century.

    STAT News 8 hours ago
  6. Scientists say NAD+ could slow aging and fight Alzheimer’s and Parkinson’s
    #6 Score 41
    Scientists say NAD+ could slow aging and fight Alzheimer’s and Parkinson’s

    A global team of leading scientists is zeroing in on a tiny but powerful molecule that could reshape how we age. Known as NAD⁺, it plays a crucial role in keeping our cells energized, repairing DNA, and maintaining overall health—but its levels steadily decline over time, potentially fueling diseases like Alzheimer’s and Parkinson’s. Researchers are now exploring ways to boost NAD⁺ using compounds like NR and NMN, with early studies hinting at improvements in memory, metabolism, and physical function.

    ScienceDaily Health 15 hours ago
  7. STAT+: FDA slams Soon-Shiong and ImmunityBio for making ‘false and misleading’ claims about a drug
    #7 Score 39
    STAT+: FDA slams Soon-Shiong and ImmunityBio for making ‘false and misleading’ claims about a drug

    Patrick Soon-Shiong, a controversial figure in the biotech industry, was accused by the FDA of making 'false and misleading' claims about a cancer treatment.

    STAT News 10 hours ago
  8. Insulin pills may soon replace daily injections
    #8 Score 27
    Insulin pills may soon replace daily injections

    For over a century, scientists have chased the dream of insulin pills, but the digestive system kept destroying the drug before it could work—forcing millions of patients to rely on daily injections. Now, researchers at Kumamoto University have developed a clever workaround using a tiny peptide that helps insulin slip through the intestinal wall.

    ScienceDaily Health 18 hours ago
  9. #9 Score 4
    Scientists discover hormone that may stop chronic back pain at its source

    A new study suggests a widely used bone hormone could help relieve chronic back pain in an unexpected way. Instead of just strengthening bone, it appears to stop pain-sensing nerves from growing into damaged spinal areas. In animal models, this led to stronger spinal tissue and reduced pain sensitivity. The findings hint at a future treatment that tackles back pain at its biological roots.

    ScienceDaily Health 23 hours ago
  10. #10 Score 1
    This new tooth powder whitens teeth without damage

    Researchers have developed a teeth-whitening powder that works with the vibrations of an electric toothbrush to safely remove stains. Unlike traditional whiteners, it not only brightens teeth but also repairs enamel and supports healthy oral bacteria. Lab tests showed dramatic whitening effects, while animal studies revealed reduced harmful microbes and inflammation. This could pave the way for a new generation of at-home dental care.

    ScienceDaily Health 1 day ago